Mobemid (Moclobemide)

Moclobemide, the active ingredient in Mobemid, is a reversible inhibitor of monoamine oxidase A (RIMA) presented as an oral tablet for oral use. It is employed to treat major depressive disorder and depressive episodes in adult patients.

GNH USA supplies Mobemid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moclobemide is indicated for depressive disorders that involve monoamine neurotransmitter dysregulation.

- Major depressive disorder: alleviates depressive symptoms and improves mood in adults. - Depressive episodes: reduces severity of episodic depressive periods associated with mood disorders.

Moclobemide may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: intermittent tension‑type pain. - Dizziness: sensation of light‑headedness, especially on standing. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Hypertensive crisis: sudden, severe elevation of blood pressure, often triggered by tyramine‑rich foods. - Serotonin syndrome: agitation, hyperthermia, and neuromuscular abnormalities when combined with other serotonergic agents. - Severe liver injury: jaundice, elevated transaminases, or hepatic failure.

Before initiating therapy with Moclobemide, clinicians should consider several safety measures.

- Liver function assessment: evaluate baseline hepatic enzymes and monitor periodically. - Blood pressure monitoring: check for hypertension, especially after dietary tyramine exposure. - Dietary restrictions: advise patients to avoid high‑tyramine foods such as aged cheeses and cured meats. - Concomitant serotonergic drugs: review all antidepressants, triptans, and linezolid to prevent serotonin excess. - Suicidal ideation evaluation: monitor mood changes, particularly during early treatment phases. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Moclobemide can interact with several medication classes, requiring careful management.

Major Interactions (Avoid): - Other MAO inhibitors: combined inhibition can precipitate hypertensive emergencies. - Selective serotonin reuptake inhibitors (SSRIs) or serotonin‑norepinephrine reuptake inhibitors (SNRIs): risk of serotonin syndrome. - Meperidine or other opioid analgesics: may cause severe hypertension.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase bleeding risk. - Antihypertensive agents: potential for additive blood pressure lowering effects.